Is Iron-Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive?

Journals Menu

Follow SCIRP

ISSN Print: 2164-3180
ISSN Online: 2164-3199
www.scirp.org/journal/ojbd
E-mail: ojbd@scirp.org

"Is Iron-Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive?"
written by Chaim Hershko, Robert Peter Gale,
published by Open Journal of Blood Diseases, Vol.1 No.1, 2011

has been cited by the following article(s):

[1]	Use of deferasirox in transfusion-dependent myelodysplastic syndromes with iron overload
	International Journal of Hematologic Oncology, 2014

[2]	Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1
	Acta haematologica, 2013

Follow SCIRP